Polymorph of 2-[3-cyano-4-(2methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid

Details for Australian Patent Application No. 2011222462 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Sokhi, Sarbjot Singh; Nath, Asok; Tandon, Nitin; Prasad, Mohan

Agent Callinan

Pub. Number AU-A-2011222462

PCT Pub. Number WO2011/107911

Priority 488/DEL/2010 04.03.10 IN

Filing date 24 February 2011

Wipo publication date 9 September 2011

International Classifications

C07D 277/56 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 - 1,3-Thiazoles

A61P 19/06 Drugs for skeletal disorders

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/107911 Priority application(s): WO2011/107911

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011222470-Process for the direct preparation of malic acid salt of sunitinib

2011222452-Stabilized alpha-galactosidase and uses thereof